Alex Tarr

Wisteria floribunda agglutinin enhances Zaire ebolavirus entry through interactions at specific N-linked glycosylation sites on the virus glycoprotein complex biorxiv.org/content/10.110…

Congratulations to Dr Richard Brown at PEI for a great paper on SARS-CoV-2 published today in PNAS news.rub.de/english/press-…

Our study on the development of a simple low-cost pathway to accurately subtype #HepatitisC in sub-Saharan Africa has just been published in the Journal of Medical Virology. 👇🏽 @PostdocPat @JonathanKBall @AlexWTarr @UoNLifeSci @OneVirology onlinelibrary.wiley.com/doi/10.1002/jm…

Another preprint from our group! How to easily sub-type the incredibly diverse #HepatitisC #virus with genomes from Sub-Saharan Africa that most commercial assays fail upon. @PostdocPat @JonathanKBall @UoNLifeSci #HCV 👇🏽 medrxiv.org/content/10.110…

@nottmhospitals and @UoNLifeSci researchers report rare bifacial weakness with paraesthesias variant of Guillain-Barré syndrome in four cases following ChAdOx1 SARS-CoV-2 vaccine. doi.org/10.1002/ana.26… Vaccination remains extremely safe and the benefits far outweigh the risks.

Our Retrospective SARS-2 screening work is now published! Several missed cases, incl one of the first known community transmissions in the UK. Great collaborative effort with @JonathanKBall, @PostdocPat, @Theo_Tsoleridis, @mattloose, #NHS and many more! doi.org/10.1099/jgv.0.…

Chuffed to have what might sadly be our final chapter on the #HCV p7 channel accepted at @eLife Huge team effort, many not on twitter, but thanks to those on here @OncoVirus_Leeds @ToshanaFoster @AbiBloy @HarrisLabLeeds @AlexWTarr @Stonehouse_Lab doi.org/10.7554/eLife.…

@SGriffin_Lab @eLife @OncoVirus_Leeds @ToshanaFoster @AbiBloy @HarrisLabLeeds @Stonehouse_Lab Congrats Steve, it's been great to work with you on this project! Hopefully not the end of the HCV work 🙄

Yes, unexpectedly found myself working on a serology study on SARS-CoV-2! Pseudotypes with @rich_urbanowicz, we're rushing to get this completed and submitted...

Congrats to all involved, this is a really interesting study and a great resource for the HCV research community

@PostdocPat @paddy_tighe5 I'm glad Robot Al is doing all the work for me!

@AlexWTarr @paddy_tighe5 Paddy's robot Al is highly convincing for sure!

High throughput #Covid19 #serology with @paddy_tighe5 and his #robot_army.

Great to be involved in the recruitment for the @UniofOxford #Chadox #Covid19 #Vaccine trial.

New paper published in Journal of Clinical Virology 'Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing' bit.ly/2YAGgaC @stuartastbury @AlexWTarr

A project we started back in 2016, before extraction-free amplification was all the rage! 'Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing' sciencedirect.com/science/articl…

Latest research just published by the @UoNLifeSci @UoNresearch virology group on human bocavirus infections.

A small milestone reached in #Covid_19 @UoNresearch today - 600th #Nottingham sample prepared for antibody testing by @AlexWTarr and #PaddyTighe at @UoNLifeSci virology labs.

Health officials say a third UK case of #coronavirus has been confirmed in a patient who caught it in an Asian country other than China. The person's being treated in a specialist unit. Jonathan Ball is Professor of emerging viruses at The University of #Nottingham:

Barney King from @OneVirology @UniNottinghamIC telling us about 'hard to pseudotype' viruses with #HepatitisC as as a model. Even clones within same patient behave differently!

@GroveLab @VirologyBochum I think JB's on it :)

This about as current as it gets: Pseudotypes used to assess cell entry of 2019-nCoV via ACE2 biorxiv.org/content/10.110…